Pharmacology I, Chapter 13: CHF
45 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary mechanism behind the edema observed in congestive heart failure (CHF)?

  • Direct damage to the capillaries resulting in leakage.
  • Increased blood pressure in the pulmonary arteries.
  • Increased sympathetic tone leading to renal salt and water retention. (correct)
  • Decreased cardiac output causing reduced vascular resistance.
  • Which drug class is typically considered to reduce water retention in heart failure patients?

  • Beta blockers
  • Aldosterone antagonists (correct)
  • Calcium channel blockers
  • ACE inhibitors
  • In a patient with CHF, which of the following is NOT a compensatory response observed?

  • Tachycardia due to increased sympathetic tone.
  • Decreased peripheral vascular resistance. (correct)
  • Cardiomegaly as a compensatory mechanism.
  • Fluid retention mediated by renin-angiotensin-aldosterone system.
  • What is the most common cause of congestive heart failure in the United States?

    <p>Coronary artery disease</p> Signup and view all the answers

    What left ventricular ejection fraction (LVEF) percentage is considered normal?

    <p>60%</p> Signup and view all the answers

    What is the primary clinical use of digoxin in patients with atrial fibrillation?

    <p>To reduce atrial flutter and fibrillation</p> Signup and view all the answers

    Why is plasma monitoring necessary for digoxin therapy?

    <p>Because of its very narrow therapeutic index</p> Signup and view all the answers

    What effect does digoxin NOT have on cardiac function?

    <p>Decreased cardiac output</p> Signup and view all the answers

    How does quinidine affect digoxin levels in the body?

    <p>It increases the plasma levels of digoxin</p> Signup and view all the answers

    What is a common adverse effect of digoxin toxicity?

    <p>Arrhythmias</p> Signup and view all the answers

    What role do azoles, such as itraconazole, play in drug interactions involving digoxin?

    <p>They alter the kinetics of digoxin by inhibiting CYP 450 enzymes</p> Signup and view all the answers

    What is the average half-life of digoxin?

    <p>40 hours</p> Signup and view all the answers

    Which statement regarding the dosage of digoxin is correct?

    <p>It is typically dosed once per day for a lifetime</p> Signup and view all the answers

    What is the primary way digoxin is eliminated from the body?

    <p>Excreted unchanged by the kidneys</p> Signup and view all the answers

    Which of the following actions of itraconazole poses a risk when taken with digoxin?

    <p>Inhibits the P-glycoprotein efflux pump</p> Signup and view all the answers

    What is considered a narrow therapeutic index concentration range for digoxin?

    <p>1-2 ng/mL</p> Signup and view all the answers

    Which of the following symptoms is NOT associated with digoxin toxicity?

    <p>Rash and itching</p> Signup and view all the answers

    What is one of the first steps in treating digoxin overdose?

    <p>Correct potassium deficiency</p> Signup and view all the answers

    How does Digibind® function in the treatment of digoxin overdose?

    <p>It binds free digoxin to reduce its effects</p> Signup and view all the answers

    Based on historical data, how many documented cases of fatalities were reported due to digoxin overdose in 1996?

    <p>16</p> Signup and view all the answers

    What is the approximate amount of digoxin that one vial of Digibind® can bind?

    <p>0.5 mg</p> Signup and view all the answers

    What was the primary focus of William Withering's work in relation to digoxin?

    <p>To establish a rational and scientific approach to drug study and treatment</p> Signup and view all the answers

    What was the primary historical significance of Withering's text on digoxin published in 1785?

    <p>It provided comprehensive guidance on using digoxin effectively and safely</p> Signup and view all the answers

    Which component is primarily affected by the action of digoxin in cardiac muscle cells?

    <p>Sodium-Potassium ATPase pump</p> Signup and view all the answers

    What is the primary outcome of digoxin's inhibition of the Sodium-Potassium ATPase pump?

    <p>Increase of intracellular sodium and subsequent increase in calcium</p> Signup and view all the answers

    What physiological change occurs as a result of increased intracellular sodium due to digoxin use?

    <p>Alteration of the Na+/Ca++ exchanger function</p> Signup and view all the answers

    How is digoxin primarily excreted from the body?

    <p>Excreted unchanged by the kidney</p> Signup and view all the answers

    Which prominent society was William Withering a member of that contributed to his work with digoxin?

    <p>The Lunar Society</p> Signup and view all the answers

    Which of the following best describes the pharmacological effect of digoxin?

    <p>It increases muscle contraction through calcium modulation</p> Signup and view all the answers

    What is the primary form of digoxin that exhibits pharmacological activity?

    <p>Free form unattached to protein</p> Signup and view all the answers

    Which of the following drugs is NOT classified as an inotropic agent used in congestive heart failure?

    <p>Captopril</p> Signup and view all the answers

    What is the role of phosphodiesterase (PDE) inhibitors in heart failure treatment?

    <p>Increase intracellular calcium and contraction force</p> Signup and view all the answers

    How does angiotensin II affect the body in the context of heart failure?

    <p>It increases peripheral resistance</p> Signup and view all the answers

    Which enzyme initiates the conversion of angiotensinogen to Angiotensin I?

    <p>Renin</p> Signup and view all the answers

    What is the potential impact of increased cAMP and cGMP levels due to PDE inhibitors?

    <p>Increased contraction strength</p> Signup and view all the answers

    What is the typical dosage range for captopril in the management of heart failure?

    <p>6 - 150 mg two to three times daily</p> Signup and view all the answers

    Which form of digoxin can be neutralized by Digibind antibodies?

    <p>All three forms of the drug</p> Signup and view all the answers

    What is a common side effect experienced by 30% of patients taking ACE inhibitors?

    <p>Cough</p> Signup and view all the answers

    Which drug class acts antagonistically to the renin-angiotensin system by blocking Angiotensin II receptor?

    <p>Angiotensin Antagonists</p> Signup and view all the answers

    What is the primary action of BNP and ANP in relation to blood pressure?

    <p>Decrease blood pressure</p> Signup and view all the answers

    What is the half-life of Nesiritide when administered IV?

    <p>18 minutes</p> Signup and view all the answers

    How does norepinephrine (NE) affect B1 receptors in the heart?

    <p>Increases intracellular calcium influx</p> Signup and view all the answers

    What is the consequence of renal damage due to ACE inhibitors and Angiotensin II receptor blockers during pregnancy?

    <p>Potential fetal kidney damage</p> Signup and view all the answers

    What natural peptide hormone is synthesized in the ventricles and plays a role in heart failure treatment?

    <p>Brain Natriuretic Peptide (BNP)</p> Signup and view all the answers

    Which receptors are primarily affected by norepinephrine to cause an increase in oxygen demand?

    <p>B1 Heart receptors</p> Signup and view all the answers

    Study Notes

    Pharmacology I, Chapter 13: CHF

    • Case Study 1: A 65-year-old man presents with shortness of breath, edema in feet/ankles, and crackles in the lungs following a viral illness. Blood pressure is 110/70 mmHg, pulse is 105 bpm, and left ventricular ejection fraction is 20% (normal ~60%). The diagnosis is Stage C, Class III heart failure, with cardiomyopathy secondary to viral infection. What treatment?

    • Case Study Treatments: Initial treatment includes a low-sodium diet and a diuretic (furosemide). An ACE inhibitor (enalapril) is added, followed by digoxin to manage continued shortness of breath. Beta blockers and eplerenone (aldosterone antagonist) are potential additional treatments.

    • CHF Overview: CHF affects approximately 5 million patients in the US. It's characterized by decreased cardiac contractility and inadequate cardiac output to meet body needs. Coronary artery disease is the most common cause in the US.

    • Homeostatic Response to CHF:

      • Tachycardia: Increased sympathetic tone.
      • Increased peripheral vascular resistance: Resulting from increased sympathetic tone.
      • Salt and water retention: Mediated by the renin-angiotensin-aldosterone system, causing blood volume increases and edema.
      • Cardiomegaly: A compensatory response to sympathetic discharge.
    • Drug Treatments for CHF:

      • (1) Positive Inotropic Drugs:
        • Cardiac glycosides.
        • PDE inhibitors.
      • (2) Vasodilators:
        • Nitrates (nitroprusside).
        • Loop diuretics.
        • Angio antagonists.
        • Nesiritide (BNP).
      • (3) Miscellaneous:
        • Beta blockers.
        • Spironolactone.
        • Thiazides.
    • Normal Cardiac Contractility: Involves decreased sensitivity of contractile proteins to calcium, amount of calcium released from the SR (sarcoplasmic reticulum), amount of trigger calcium, movement of calcium against its sodium gradient, and alteration of sodium/potassium ATPase (digoxin).

    Digoxin

    • Description: Digoxin (Lanoxin®), a cardiac glycoside, is the most commonly used glycoside derived from foxglove.

    • Mechanism of Action: Digoxin inhibits the Na+/K+ ATPase pump, increasing intracellular calcium, thus strengthening cardiac muscle contractions.

    • Pharmacological Effects: Specifically, it increases cardiac contractility, ventricular ejection volume, cardiac output, and renal perfusion. Additionally, it can cause early and toxic responses, as seen in the electrical effects.

    • Clinical Uses: Digoxin is used to reduce symptoms of CHF and atrial fibrillation.

    • Drug Interactions: Quinidine displaces digoxin from tissue binding sites, increasing digoxin levels. Itraconazole inhibits the P-glycoprotein pump, leading to an increased risk of digoxin toxicity.

    • Toxicity: Digoxin toxicity includes nausea, vomiting, diarrhea, visual disturbances (color changes), arrhythmias, and potentially life-threatening CNS effects.

    • Overdose Treatment: Includes correction of any potassium deficiency, use of digoxin antibodies (Digibind®) to bind digoxin, and close monitoring of serum digoxin concentrations.

    Digoxin in the Body

    • Forms of Digoxin:
      • Free form (70%): Active form.
      • Inactive bound to albumin: Not pharmacologically active.
      • Bound to tissue receptors (Na+/K+ ATPase pumps): Where Digibind® antibodies bind.

    PDE Inhibitors

    • Description: These drugs are inotropic agents used in CHF. Milrinone is a specific example of an IV-only PDE inhibitor that can be used in acute heart failure. Examples include theophylline, amrinone, and milrinone.

    • Mechanism of Action: PDE inhibitors inhibit the phosphodiesterase (PDE) enzyme, resulting in increased intracellular calcium and improved contractility.

    ACE Inhibitors

    • Mechanism of Action: ACE inhibitors decrease blood pressure by blocking the conversion of angiotensin I to angiotensin II. This reduces vasoconstriction and aldosterone secretion. They also increase renal blood flow.

    • Examples: Examples include captopril, enalapril, and benazepril.

    • Clinical Significance: Approximately 30% of patients experience a cough, and they are contraindicated during pregnancy due to potential fetal renal damage.

    Angiotensin Antagonists

    • Mechanism of Action: A second class of drugs used in CHF, acting antagonistically to the renin-angiotensin system. This can be accomplished by two different types of drugs:
    • block Angio II formation (ACE inhibitors)
    • Block Angio II receptor

    Angio II Receptor Blockers

    • Mechanism of Action: Specifically block the receptor for Angio II, reducing its effects.

    • Examples: Losartan is an example.

    • Clinical Significance: Similar clinical effects to ACE inhibitors, but with a lower incidence of cough. Fetal kidney damage is still a risk, and these agents should never be used during pregnancy.

    BNP Agonist

    • Description: BNP is a naturally occurring peptide hormone synthesized in the ventricles that counteracts the renin-angiotensin-aldosterone system and lowers blood pressure. ANP is a similar, but the atria synthesizes this peptide hormone.

    • Function: These hormones are natriuretic, meaning they increase sodium excretion.

    • Examples: Nesiritide (Natrecor®)

    • Clinical Significance: The drug form, nesiritide, is used intravenously (IV) in acute heart failure cases. Serum levels of the natural BNP are often utilized as a screening tool to detect cardiac disease.

    Beta Receptors

    • Mechanism of Action: Beta-1 receptors in the heart increase heart rate, blood pressure, and oxygen demand. Beta-2 receptors in the periphery trigger vasoconstriction. When NE binds to beta 1 receptors, Ca++ flows into the cardiac cells, strengthening their contractions.

    • Examples: NE (norepinephrine), metoprolol (Lopressor®), bisoprolol, and carvedilol.

    • Clinical Significance: Beta blockers are used to slow down the heart rate in patients with heart issues. By blocking the stimulation of beta receptors by catecholamines, these medications offer a different mechanism of action to manage patients with congestive heart failure (CHF).

    Case Study Treatment summary

    • Drug treatments are tailored in CHF depending on disease severity (mild, moderate, severe).
    • This case involves a moderate presentation of the disorder.
    • For the moderate case detailed in the example case study, the treatment involves digoxin and ACE inhibitors, and diuretics.
    • Use of beta blockers and other medications such as vasodilators may be added to moderate CHF management based on disease progression and the specific condition of the patient.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    PM716 C13 CHF Slides PDF

    Description

    This quiz explores the complexities of Congestive Heart Failure (CHF) through case studies, focusing on symptoms, diagnostic criteria, and treatment options. Learners will evaluate appropriate pharmacological interventions based on patient presentations and current guidelines. Prepare to deepen your understanding of managing heart failure.

    More Like This

    CHF Treatment with Vasodilators
    18 questions
    Congestive Heart Failure Management
    18 questions
    MedGard Congestive Heart Failure Quiz
    37 questions
    Congestive Heart Failure Management Quiz
    29 questions
    Use Quizgecko on...
    Browser
    Browser